Thrivent Financial For Lutherans Vanda Pharmaceuticals Inc. Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $4,951 - $6,709	-1,465 Reduced 4.65%	30,009 $126,000
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $235,198 - $361,041	-54,953 Reduced 63.58%	31,474 $136,000
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $16,921 - $19,932	-2,868 Reduced 3.21%	86,427 $570,000
Q1 2023 May 17, 2023	SELL	$6.18 - $7.99 $10,950 - $14,158	-1,772 Reduced 1.95%	89,295 $606,000
Q4 2022 Feb 08, 2023	SELL	$6.87 - $10.96 $2,892 - $4,614	-421 Reduced 0.46%	91,067 $673,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $339,736 - $423,230	35,989 Added 64.85%	91,488 $904,000
Q2 2022 Aug 16, 2022	BUY	$9.31 - $11.84 $94,449 - $120,116	10,145 Added 22.37%	55,499 $605,000
Q1 2022 May 13, 2022	BUY	$10.84 - $16.55 $162 - $248	15 Added 0.03%	45,354 $513,000
Q4 2021 Feb 16, 2022	BUY	$15.69 - $21.14 $5,742 - $7,737	366 Added 0.81%	45,339 $711,000
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $6,892 - $9,550	-449 Reduced 0.99%	44,973 $771,000
Q2 2021 Aug 19, 2021	BUY	$15.71 - $21.51 $5,294 - $7,248	337 Added 0.75%	45,422 $977,000
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $2,482 - $3,751	-185 Reduced 0.41%	45,085 $677,000
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $1,289 - $1,822	-132 Reduced 0.29%	45,270 $595,000
Q2 2020 Aug 12, 2020	BUY	$9.66 - $12.02 $6,771 - $8,426	701 Added 1.57%	45,402 $519,000
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $16,732 - $37,480	2,231 Added 5.25%	44,701 $463,000
Q4 2019 Feb 13, 2020	BUY	$12.38 - $17.47 $2,339 - $3,301	189 Added 0.45%	42,470 $697,000
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $12,036 - $15,489	981 Added 2.38%	42,281 $561,000
Q2 2019 Aug 13, 2019	BUY	$13.37 - $18.85 $16,231 - $22,883	1,214 Added 3.03%	41,300 $582,000
Q1 2019 May 14, 2019	BUY	$17.59 - $31.05 $52,981 - $93,522	3,012 Added 8.12%	40,086 $738,000
Q4 2018 Feb 15, 2019	BUY	$18.97 - $31.47 $15,460 - $25,648	815 Added 2.25%	37,074 $969,000
Q3 2018 Nov 15, 2018	BUY	$18.25 - $23.0 $661,726 - $833,957	36,259 New	36,259 $832,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$39.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$19.5 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$17.6 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$11.4 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$11 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $274M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account